figshare: https://api.figshare.com/v2/articles/28823159
version: 2.1.0
datasets:
  beataml:
    description: Beat acute myeloid leukemia (BeatAML) focuses on acute myeloid leukemia
      tumor data. Data includes drug response, proteomics, and transcriptomics datasets.
    references:
    - citation: Bottomly D, Long N, Schultz AR, et al. Integrative analysis of drug
        response and clinical outcome in acute myeloid leukemia. Cancer Cell. 2022;40(8):850-864.e9.
      doi: https://doi.org/10.1016/j.ccell.2022.07.002
    - citation: Pino JC, Posso C, Joshi SK, et al. Mapping the proteogenomic landscape
        enables prediction of drug response in acute myeloid leukemia. Cell Rep Med.
        2024;5(1):101359.
      doi: https://doi.org/10.1016/j.xcrm.2023.101359
  bladderpdo:
    description: Tumor Evolution and Drug Response in Patient-Derived Organoid Models of Bladder Cancer
      Data includes transcriptomics, mutations, copy number, and drug response data.
    references:
    - citation: Suk Hyung Lee, Wenhuo Hu, Justin T. Matulay, Mark V. Silva, 
        Tomasz B. Owczarek, Kwanghee Kim, Chee Wai Chua, LaMont J. Barlow, 
        Cyriac Kandoth, Alanna B. Williams, Sarah K. Bergren, Eugene J. Pietzak, 
        Christopher B. Anderson, Mitchell C. Benson, Jonathan A. Coleman, Barry S. Taylor, 
        Cory Abate‑Shen, James M. McKiernan, Hikmat Al‑Ahmadie, David B. Solit, Michael M. Shen. 
        Tumor Evolution and Drug Response in Patient‑Derived Organoid Models of Bladder Cancer. 
        Cell. 2018;173(2):515‑528.e17.
      doi: https://doi.org/10.1016/j.cell.2018.03.017
  ccle:
    description: Cancer Cell Line Encyclopedia (CCLE).
    references:
    - citation: Barretina J, Caponigro G, Stransky N, et al. The Cancer Cell Line
        Encyclopedia enables predictive modelling of anticancer drug sensitivity Nature.
        2012;483(7391):603-607. Published 2012 Mar 28.
      doi: https://doi.org/10.1038/nature11003
  cptac:
    description: The Clinical Proteomic Tumor Analysis Consortium (CPTAC) project
      is a collaborative network funded by the National Cancer Institute (NCI) focused
      on improving our understanding of cancer biology through the integration of
      transcriptomic, proteomic, and genomic data.
    references:
    - citation: Lindgren CM, Adams DW, Kimball B, et al. Simplified and Unified Access
        to Cancer Proteogenomic Data. J Proteome Res. 2021;20(4):1902-1910.
      doi: doi:10.1021/acs.jproteome.0c00919
  ctrpv2:
    description: Cancer Therapeutics Response Portal version 2 (CTRPv2)
    references:
    - citation: Rees MG, Seashore-Ludlow B, Cheah JH, et al. Correlating chemical
        sensitivity and basal gene expression reveals mechanism of action. Nat Chem
        Biol. 2016;12(2):109-116.
      doi: doi:10.1038/nchembio.1986
    - citation: Seashore-Ludlow B, Rees MG, Cheah JH, et al. Harnessing Connectivity
        in a Large-Scale Small-Molecule Sensitivity Dataset. Cancer Discov. 2015;5(11):1210-1223.
      doi: doi:10.1158/2159-8290.CD-15-0235
    - citation: Basu A, Bodycombe NE, Cheah JH, et al. An interactive resource to
        identify cancer genetic and lineage dependencies targeted by small molecules.
        Cell. 2013;154(5):1151-1161.
      doi: doi:10.1016/j.cell.2013.08.003
  fimm:
    description: Institute for Molecular Medicine Finland (FIMM) dataset.
    references:
    - citation: "Mpindi JP, Yadav B, \xD6stling P, et al. Consistency in drug response\
        \ profiling. Nature. 2016;540(7631):E5-E6."
      doi: doi:10.1038/nature20171
    - citation: Pemovska T, Kontro M, Yadav B, et al. Individualized systems medicine
        strategy to tailor treatments for patients with chemorefractory acute myeloid
        leukemia. Cancer Discov. 2013;3(12):1416-1429.
      doi: doi:10.1158/2159-8290.CD-13-0350
  gcsi:
    description: The Genentech Cell Line Screening Initiative (gCSI)
    references:
    - citation: Haverty PM, Lin E, Tan J, et al. Reproducible pharmacogenomic profiling
        of cancer cell line panels. Nature. 2016;533(7603):333-337.
      doi: https://doi.org/10.1038/nature17987
    - citation: Klijn C, Durinck S, Stawiski EW, et al. A comprehensive transcriptional
        portrait of human cancer cell lines. Nat Biotechnol. 2015;33(3):306-312.
      doi: https://doi.org/10.1038/nbt.3080
  gdscv1:
    description: Genomics of Drug Sensitivity in Cancer (GDSC) v1
    references:
    - citation: Garnett MJ, Edelman EJ, Heidorn SJ, et al. Systematic identification
        of genomic markers of drug sensitivity in cancer cells. Nature. 2012;483(7391):570-575.
        Published 2012 Mar 28.
      doi: doi:10.1038/nature11005
    - citation: Iorio F, Knijnenburg TA, Vis DJ, et al. A Landscape of Pharmacogenomic
        Interactions in Cancer. Cell. 2016;166(3):740-754.
      doi: doi:10.1016/j.cell.2016.06.017
    - citation: 'Yang W, Soares J, Greninger P, et al. Genomics of Drug Sensitivity
        in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer
        cells. Nucleic Acids Res. 2013;41(Database issue):D955-D961.'
      doi: doi:10.1093/nar/gks1111
  gdscv2:
    description: Genomics of Drug Sensitivity in Cancer (GDSC) v2
    references:
    - citation: Garnett MJ, Edelman EJ, Heidorn SJ, et al. Systematic identification
        of genomic markers of drug sensitivity in cancer cells. Nature. 2012;483(7391):570-575.
        Published 2012 Mar 28.
      doi: doi:10.1038/nature11005
    - citation: Iorio F, Knijnenburg TA, Vis DJ, et al. A Landscape of Pharmacogenomic
        Interactions in Cancer. Cell. 2016;166(3):740-754.
      doi: doi:10.1016/j.cell.2016.06.017
    - citation: 'Yang W, Soares J, Greninger P, et al. Genomics of Drug Sensitivity
        in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer
        cells. Nucleic Acids Res. 2013;41(Database issue):D955-D961.'
      doi: doi:10.1093/nar/gks1111
  hcmi:
    description: Human Cancer Models Initiative (HCMI) encompasses numerous cancer
      types and includes cell line, organoid, and tumor data. Data includes the transcriptomics,
      somatic mutation, and copy number datasets.
  mpnst:
    description: Malignant Peripheral Nerve Sheath Tumor is a rare, agressive sarcoma
      that affects peripheral nerves throughout the body.
    references:
    - citation: Dehner C, Moon CI, Zhang X, et al. Chromosome 8 gain is associated
        with high-grade transformation in MPNST. JCI Insight. 2021;6(6):e146351. Published
        2021 Mar 22.
      doi: https://doi.org/10.1172/jci.insight.146351
  mpnstpdx:
    description: Patient derived xenograft data for MPNST
  nci60:
    description: National Cancer Institute 60
    references:
    - citation: Shoemaker RH. The NCI60 human tumour cell line anticancer drug screen.
        Nat Rev Cancer. 2006;6(10):813-823.
      doi: doi:10.1038/nrc1951
  pancpdo:
    description: Organoid Profiling Identifies Common Responders to Chemotherapy in Pancreatic Cancer
      Data includes transcriptomics, mutations, copy number, and drug response data.
    references:
    - citation: Hervé Tiriac, Pascal Belleau, Dannielle D. Engle, Dennis Plenker, Astrid Deschênes, 
        Tim D. D. Somerville, Fieke E. M. Froeling, Richard A. Burkhart, Robert E. Denroche, Gun‑Ho Jang,
        Koji Miyabayashi, C. Megan Young, Hardik Patel, Michelle Ma, Joseph F. LaComb, Randze L. D. Palmaira, 
        Ammar A. Javed, Jasmine C. Huynh, Molly Johnson, Kanika Arora, Nicolas Robine, Minita Shah, 
        Rashesh Sanghvi, Austin B. Goetz, Cinthya Y. Lowder, Laura Martello, Else Driehuis, Nicolas LeComte, 
        Gokce Askan, Christine A. Iacobuzio‑Donahue, Hans Clevers, Laura D. Wood, Ralph H. Hruban, Elizabeth Thompson, 
        Andrew J. Aguirre, Brian M. Wolpin, Aaron Sasson, Joseph Kim, Maoxin Wu, Juan C. Bucobo, Peter Allen, 
        Divyesh V. Sejpal, William Nealon, James D. Sullivan, Jordan M. Winter, Phyllis A. Gimotty, Jean L. Grem, 
        Dominick J. DiMaio, Jonathan M. Buscaglia, Paul M. Grandgenett, Jonathan R. Brody, Michael A. Hollingsworth, 
        Grainne M. O’Kane, Faiyaz Notta, Edward Kim, James M. Crawford, Craig Devoe, Allyson Ocean, Christopher L. Wolfgang, 
        Kenneth H. Yu, Ellen Li, Christopher R. Vakoc, Benjamin Hubert, Sandra E. Fischer, Julie M. Wilson, Richard Moffitt, 
        Jennifer Knox, Alexander Krasnitz, Steven Gallinger, David A. Tuveson. Organoid Profiling Identifies Common 
        Responders to Chemotherapy in Pancreatic Cancer. Cancer Discov. 2018;8(9):1112‑1129.
      doi: https://doi.org/10.1158/2159-8290.CD-18-0349
  prism:
    description: Profiling Relative Inhibition Simultaneously in Mixtures
    references:
    - citation: Corsello SM, Nagari RT, Spangler RD, et al. Discovering the anti-cancer
        potential of non-oncology drugs by systematic viability profiling. Nat Cancer.
        2020;1(2):235-248.
      doi: doi:10.1038/s43018-019-0018-6
    - citation: Yu C, Mannan AM, Yvone GM, et al. High-throughput identification of
        genotype-specific cancer vulnerabilities in mixtures of barcoded tumor cell
        lines. Nat Biotechnol. 2016;34(4):419-423.
      doi: doi:10.1038/nbt.3460
  sarcpdo:
      description: The landscape of drug sensitivity and resistance in sarcoma
        Data includes transcriptomics, mutations, and drug response data.
      references:
      - citation: Ahmad Al Shihabi, Peyton J. Tebon, Huyen T. L. Nguyen, 
          Jomjit Chantharasamee, Sara Sartini, Ardalan Davarifar, Alexandra Y. Jensen, 
          Miranda Diaz‑Infante, Hannah Cox, Alfredo E. Gonzalez, Summer Norris, Jantzen Sperry, 
          Jonathan Nakashima, Nasrin Tavanaie, Helena Winata, Sorel T. Fitz‑Gibbon, 
          Takafumi N. Yamaguchi, Jae H. Jeong, Sarah Dry, Arun S. Singh, Bartosz Chmielowski, 
          Joseph G. Crompton, Anusha K. Kalbasi, Fritz C. Eilber, Francis Hornicek, 
          Nicholas M. Bernthal, Scott D. Nelson, Paul C. Boutros, Noah C. Federman, Jane Yanagawa, 
          Alice Soragni. The landscape of drug sensitivity and resistance in sarcoma. 
          Cell Stem Cell. 2024;31(10):1524‑1542.e4.
        doi: https://doi.org/10.1016/j.stem.2024.08.010
